Article

CEBF virtual symposium showcases vision research from three Northeast Ohio institutions

Cleveland Eye Bank Foundation (CEBF) will feature nine researchers from three eye institutions on February 15, from 3 to 5 pm Eastern, for its second annual virtual vision research symposium.

CEBF virtual symposium showcases vision research from three Northeast Ohio institutions

Nine researchers from three eye institutions will present their most current studies and breakthroughs against leading blinding eye diseases.

Cleveland Eye Bank Foundation (CEBF) will feature nine researchers from three eye institutions on February 15, from 3 to 5 pm Eastern, for its second annual virtual vision research symposium.

Leading researchers from three of Northeast Ohio’s medical institutions—Cleveland Clinic Cole Eye Institute, University Hospitals Eye Institute, and Akron Children’s Hospital Vision Center—will present their most current studies and breakthroughs against leading blinding eye diseases including diabetic retinopathy, age-related macular degeneration, glaucoma, and children’s vision issues.

“Funding provided by CEBF is critical for our mission to improve our understanding and find cures for diseases causing blindness,” said Bela Anand-Apte, MBBS, PhD, MBA, symposium moderator. “We look forward to sharing some of the progress we have made this past year.”

The researchers presenting include:

  • Richard Hertle, MD, Chief of Pediatric Ophthalmology and The Children's Vision Center, Akron Children's Hospital
  • Daniel Martin, MD, Chair, Cleveland Clinic Cole Eye Institute
  • Douglas Rhee, MD, Director, University Hospitals Eye Institute; Professor and Chairman, CWRU Department of Ophthalmology and Visual Sciences
  • Fatema Ghasia, MD, Associate Professor, Cleveland Clinic Cole Eye Institute; Director of Vision Neurosciences and Ocular Motility Laboratory, Cleveland Clinic
  • Stephanie Hagstrom, PhD, Associate Professor of Ophthalmology, Cleveland Clinic Cole Eye Institute
  • Sudha Iyengar, PhD, Professor of Population & Quantitative Health Sciences, Genetics & Genome Sciences and Ophthalmology & Visual Sciences, Case Western Reserve University; Staff, Louis Stokes Veterans Affairs Medical Center - Cleveland
  • Shigemi Matsuyama, DVM, PhD, Associate Professor, Department of Ophthalmology & Visual Sciences, Case Western Reserve University School of Medicine
  • Neal S. Peachey, PhD, Staff, Cleveland Clinic Cole Eye Institute; Associate Chief of Staff - Research, Cleveland VA Medical Center
  • Johannes Von Lintig, PhD, Professor of Pharmacology and Director of Visual Science Training Program, Case Western Reserve University; President, International Carotenoid Society

“We are excited to host leading vision researchers and physicians as they share their breakthrough discoveries at our symposium and share with our constituents the impact of their investment with Cleveland Eye Bank Foundation,” said Executive Director Debbie May-Johnson.

Register for this free event highlighting advancements toward restored sight for future generations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
© 2025 MJH Life Sciences

All rights reserved.